Drug-induced liver disorders: implications for drug development and regulation.
about
Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An OverviewStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewComparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicityHemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitroNon invasive in vivo investigation of hepatobiliary structure and function in STII medaka (Oryzias latipes): methodology and applications.Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.Drug-induced liver injury in older adults.Tradition and toxicity: evidential cultures in the kava safety debate.Protective effect of bixin on carbon tetrachloride-induced hepatotoxicity in rats.Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity.Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B.Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples.Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseCometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.Synergistic drug-cytokine induction of hepatocellular death as an in vitro approach for the study of inflammation-associated idiosyncratic drug hepatotoxicity.Identification and categorization of liver toxicity markers induced by a related pair of drugs.Clinical perspectives on xenobiotic-induced hepatotoxicity.Causality assessment in drug-induced hepatotoxicity.An Update on Treatment of Drug-Induced Liver Injury.Protective Role of Phyllanthus niruri Extract against Thioacetamide-Induced Liver Cirrhosis in Rat ModelDrug bioactivation, covalent binding to target proteins and toxicity relevance.Idiosyncratic drug hepatotoxicity.Systematic review of the pharmacological treatment of alcohol use disorders in individuals infected with hepatitis C.Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.Increased susceptibility of natural killer T-cell-deficient mice to acetaminophen-induced liver injury.Elevated liver enzymes associated with dronedarone for atrial fibrillation.Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.Hepatoprotective and antioxidant effects of saponarin, isolated from Gypsophila trichotoma Wend. on paracetamol-induced liver damage in rats.Assessment of drug-induced liver injury in clinical practice.Expression of miRNA-122 Induced by Liver Toxicants in Zebrafish.Acute and Fatal Isoniazid-Induced Hepatotoxicity: A Case Report and Review of the Literature.HIV-related liver disease: ARV drugs, coinfection, and other risk factors.Inflammatory stress and idiosyncratic hepatotoxicity: hints from animal models.Current concepts of mechanisms in drug-induced hepatotoxicity.Tumor suppressive functions of p53A case of probable esomeprazole-induced transient liver injury in a pregnant woman with hyperemesis.The role of metabolic biomarkers in drug toxicity studies.
P2860
Q26767516-A2FED9FF-44ED-46FC-B7E4-1219DBED55F6Q27008867-B5B36771-5C8B-4BD1-B482-23DBC01E0AB1Q28487995-9CA4E01E-984C-48C8-B740-E30ED2339980Q30412693-BDFF1F0E-6A3C-4DB1-9531-0F11512BF64BQ30484719-D48E0620-9005-4F57-B1AB-4EA475D82F98Q33584259-205A1C98-85CA-42B0-AE41-E7278DA87A7CQ33653566-202D6FED-6478-4C14-923C-DC734C9B34E5Q33836130-D4A12CB7-11F2-40AE-9253-672753F0938DQ33949227-F39F22C7-A798-46A3-9D52-E136AEE30FE5Q34212057-197D154E-B614-4BCA-BA4D-64447626F44CQ34318543-519EAE6F-1FF6-4DE0-8458-1CAA23E0A31DQ34376979-4EC7DEB3-508D-41BD-84ED-50190173C056Q34409132-58E6EE0C-24C7-40DD-A845-EAC0DEEADE50Q34546734-44CFB378-E84C-45EC-BBCC-92D7465F471FQ34784297-596FFE6D-BE7D-4CF3-86F8-5E50AE6F5A00Q34915414-E58496B3-DCE4-40DF-89DF-DC9B8AE0208AQ35026973-6DE9516D-A82E-46DF-94E9-D64333C7803CQ35162180-042AE2B8-F604-49E2-9739-B0C636855A0AQ35828028-F2258E00-FF60-4A04-BA3D-2D37EAB148C8Q35842573-9A2C7BB1-4F31-4303-803B-02B907D5B6ECQ35905999-E5739436-3339-4F16-AB9A-C702C09D9E87Q35979117-165352A8-CCBF-4C80-9439-37A361E64056Q36061821-075DBE6C-BFC7-4B1C-8D25-18F1B3F50EADQ36148442-B278316D-BA33-43D1-BA10-06EFB137AA56Q36259199-18934D72-298B-4043-A947-090DA8A8B2B6Q36304927-AB1BC40E-7624-4565-80F4-E46A4F08EE96Q36375764-15316B5B-B04C-4CC3-B694-B3EEB6E5C2D8Q36756077-EB476FA3-AD39-4FC7-94A3-58744B762E1AQ36871366-2E7C66D1-1408-4CA9-BEB7-020C7CA49C2BQ36919924-D78CB68D-22C4-4A10-B73D-FE0F26C55D32Q37002757-C1D1ACDD-D6C9-46D2-A1E3-435A46194CFEQ37114105-59A64F19-0EB8-49C0-A834-2913FFAA29F8Q37181019-F566BA7F-D7AA-460D-8AEC-767712168B78Q37239604-2DBFD790-60D5-4E19-9F37-DB74A49E5A56Q37391122-12EA326C-11EA-46BB-A3AD-CE5112D8C85BQ37391731-93F3E1AA-FE38-4FA6-AAB6-88A9F22B3954Q37394799-AAEC159B-3E4E-4DDD-AB89-6CFFB6A9A623Q37412688-9F33B5C8-D58F-4C2C-B910-1686121CCF9BQ37515629-E76B0870-BE32-4AEE-A8D9-185E18A66705Q37658689-B795B74C-E65A-414A-8481-BD45C47624E2
P2860
Drug-induced liver disorders: implications for drug development and regulation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Drug-induced liver disorders: implications for drug development and regulation.
@ast
Drug-induced liver disorders: implications for drug development and regulation.
@en
Drug-induced liver disorders: implications for drug development and regulation.
@nl
type
label
Drug-induced liver disorders: implications for drug development and regulation.
@ast
Drug-induced liver disorders: implications for drug development and regulation.
@en
Drug-induced liver disorders: implications for drug development and regulation.
@nl
prefLabel
Drug-induced liver disorders: implications for drug development and regulation.
@ast
Drug-induced liver disorders: implications for drug development and regulation.
@en
Drug-induced liver disorders: implications for drug development and regulation.
@nl
P1433
P1476
Drug-induced liver disorders: implications for drug development and regulation.
@en
P2093
N Kaplowitz
P304
P356
10.2165/00002018-200124070-00001
P577
2001-01-01T00:00:00Z
P6179
1046952978